PK

Pravinkumar Kanmal Purohit

Active Director Director DIN 09333712
DIN 09333712 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Pravinkumar Kanmal Purohit

Data last updated:

Pravinkumar Kanmal Purohit is a Director at N Lexo Pharma Private Limited (since 2021). The company operates in Chemicals. N Lexo Pharma Private Limited reported revenue of ₹73.2 Lakh (FY 2024).

DIN 09333712
Primary Designation Director
Industry Chemicals
First Appointment 25 Sep 2021
Oldest Company Age 5 yrs
Largest company N Lexo Pharma Private Limited · ₹73.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
N Lexo Pharma Private Limited U24290GJ2021PTC125867
Director25 Sep 20212021₹73.2 Lakh (FY 2024)Active

Board colleagues of Pravinkumar Kanmal Purohit

Directorship timeline

Open interactive timeline →
N Lexo Pharma Private Limited
Premium access

Shareholding and investment profile for Pravinkumar Kanmal Purohit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravinkumar Kanmal Purohit

Pravinkumar Kanmal Purohit currently holds 1 directorship: N Lexo Pharma Private Limited (Director, since 25 Sep 2021, revenue ₹73.2 Lakh (FY 2024)).

Pravinkumar Kanmal Purohit was first appointed on 25 Sep 2021 as Director at N Lexo Pharma Private Limited.

The current boards of Pravinkumar Kanmal Purohit's companies include Ashishkumar Sharma (N Lexo Pharma Private Limited), Bhavesh Ashokkumar Nayak (N Lexo Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available